HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A single-chain antibody generation system yielding CAR-T cells with superior antitumor function.

Abstract
Cancer immunotherapy using T cells redirected with chimeric antigen receptor (CAR) has shown a lot of promise. We have established a single-chain antibody (scFv) generation system in which scFv library-expressing CAR-T cells can be screened appropriately based on their antitumor functions. A variable region library containing the variable and J regions of the human immunoglobulin light or heavy chain was fused with the variable region of a heavy or light chain encoded by an existing tumor-specific antibody to generate a new scFv library. Then, scFv library-expressing CAR-T cells were generated and stimulated with target cells to concentrate the antigen-specific population. Using this system, target-specific recognition of CAR-T cells appeared to be finely tuned by selecting a new variable region. Importantly, we have demonstrated that the newly optimized scFv-expressing CAR-T cells had better proliferation capacity and durable phenotypes, enabling superior reactivity against advanced tumors in vivo in comparison with the original CAR-T cells. Therefore, the optimization of an scFv is needed to maximize the in vivo antitumor functions of CAR-T cells. This system may allow us to adjust an immunological synapse formed by an scFv expressed by CAR-T cells and a target antigen, representing an ideal form of CAR-T-cell immunotherapy.
AuthorsToshiki Ochi, Masaki Maruta, Kazushi Tanimoto, Fumitake Kondo, Toshihiro Yamamoto, Mie Kurata, Hiroshi Fujiwara, Junya Masumoto, Katsuto Takenaka, Masaki Yasukawa
JournalCommunications biology (Commun Biol) Vol. 4 Issue 1 Pg. 273 (03 02 2021) ISSN: 2399-3642 [Electronic] England
PMID33654176 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Immunoglobulin Heavy Chains
  • Immunoglobulin Light Chains
  • Immunoglobulin Variable Region
  • Receptors, Chimeric Antigen
  • Single-Chain Antibodies
Topics
  • Animals
  • Female
  • Humans
  • Immunoglobulin Heavy Chains (genetics, metabolism)
  • Immunoglobulin Light Chains (genetics, metabolism)
  • Immunoglobulin Variable Region (genetics, metabolism)
  • Immunological Synapses
  • Immunotherapy, Adoptive
  • Jurkat Cells
  • K562 Cells
  • Lymphoma (genetics, immunology, metabolism, therapy)
  • Mice, Inbred NOD
  • Mice, SCID
  • Receptors, Chimeric Antigen (genetics, metabolism)
  • Single-Chain Antibodies (genetics, metabolism)
  • T-Lymphocytes (immunology, metabolism, transplantation)
  • Tumor Burden
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: